| 产品描述: | Sepimostat (FUT-187 free base) exhibits neuroprotective activity via NR2B N-methyl-D-aspartate receptor antagonism at the Ifenprodil-binding site of the NR2B subunit. Sepimostat inhibits the Ifenprodil binding with a Ki value of 27.7 µM |
| 靶点: |
iGluR |
| 体外研究: |
Sepimostat (1 to 100 nmol/eye, intravitreal injection) exhibits significant neuroprotective effect. |
| 体内研究: |
Sepimostat (1 to 100 nmol/eye, intravitreal injection) exhibits significant neuroprotective effect. Animal Model: Male Sprague Dawley rats weighing 150-300 g. Dosage: Intravitreal injection. Administration: 1 to 100 nmol/eye. Result: Exhibited neuroprotective effects significantly. |
| 参考文献: |
1. Masahiro Fuwa, et al. Nafamostat and Sepimostat Identified as Novel Neuroprotective Agents via NR2B N-methyl-D-aspartate Receptor Antagonism Using a Rat Retinal Excitotoxicity Model. Sci Rep. 2019 Dec 31;9(1):20409. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 备注: |
Sepimostat (FUT-187 free base) 通过拮抗 NR2B N-methyl-D-aspartate 受体发挥神经保护作用, 作用位点在 NR2B 亚基的 Ifenprodil 结合位点。Sepimostat 抑制 Ifenprodil 结合的Ki 值为27.7 µM。 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.678 ml |
13.39 ml |
26.78 ml |
| 5 mM |
0.536 ml |
2.678 ml |
5.356 ml |
| 10 mM |
0.268 ml |
1.339 ml |
2.678 ml |
| 50 mM |
0.054 ml |
0.268 ml |
0.536 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |